Holen Sie sich die Stockscreener-App
3.95
2.86%
0.11
Handel nachbörslich:
3.95
Schlusskurs vom Vortag:
$3.84
Offen:
$3.86
24-Stunden-Volumen:
2.20M
Relative Volume:
0.71
Marktkapitalisierung:
$444.30M
Einnahmen:
$1.88B
Nettoeinkommen (Verlust:
$-534.51M
KGV:
-0.7672
EPS:
-5.1483
Netto-Cashflow:
$4.76M
1W Leistung:
-0.25%
1M Leistung:
+27.42%
6M Leistung:
-4.59%
1J Leistung:
-46.33%
1-Tages-Spanne:
$3.795
$3.985
1-Wochen-Bereich:
$3.715
$4.14
52-Wochen-Spanne:
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.95 | 431.93M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Evolent Health : EVH - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
EVH Maintained by Citigroup -- Price Target Raised to $5.50 - GuruFocus
Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating - Moomoo
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5.5 - Moomoo
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges - Investing.com UK
Evolent Health Price Target Raised to $6.00/Share From $4.00 by Canaccord Genuity - Moomoo
EVH Maintained by Canaccord Genuity -- Price Target Raised to $6 - GuruFocus
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Canaccord raises Evolent Health stock price target on new wins By Investing.com - Investing.com South Africa
Canaccord raises Evolent Health stock price target on new wins - Investing.com
AI-focused health plan tools get new steward at Quest Analytics - Stock Titan
TD Cowen raises Evolent Health stock price target on recovery track - Investing.com UK
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $8 - Moomoo
TD Cowen raises Evolent Health stock price target on recovery track By Investing.com - Investing.com South Africa
Evolent Health Q1 Earnings Call Highlights - MarketBeat
Evolent Health, Inc (NYSE:EVH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $6 - Moomoo
Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - simplywall.st
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Evolent Health Earnings Call Balances Growth and Risk - TipRanks
MSN Money - MSN
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $5 - Moomoo
Evolent (EVH) Q1 2026 Earnings Call Transcript - AOL.com
BMO Capital Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Evolent Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises By Investing.com - Investing.com Australia
Evolent Health: Q1 Earnings Snapshot - theheraldreview.com
EVH Maintained by Needham -- Price Target Raised to $5.00 - GuruFocus
Evolent Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:EVH) 2026-05-07 - Seeking Alpha
Needham Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5 - Moomoo
Why is Evolent Health (EVH) stock soaring today - MSN
Why Is Evolent Health (EVH) Stock Soaring Today - TradingView
Earnings call transcript: Evolent Health Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
4.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):